EQUITY RESEARCH MEMO

3NT Medical

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)55/100

3NT Medical is a privately held medical device company headquartered in Irvine, California, with additional operations in Israel. Founded in 2015, the company specializes in developing sterile, single-use endoscopes tailored for ear, nose, and throat (ENT) procedures. Its product portfolio includes the Colibri™ Micro ENT Scope and the Peregrine™ Drivable ENT Scope, designed to improve visualization and workflow for otolaryngologists. By focusing on single-use devices, 3NT Medical aims to reduce cross-contamination risks and enhance procedural efficiency. The company has secured a foothold in a market segment that values convenience and infection control, particularly in outpatient settings. As a private entity, detailed financials and regulatory milestones are not publicly disclosed, but the company's patents and product differentiation position it within the growing single-use endoscope market.

Upcoming Catalysts (preview)

  • Q3 2026FDA 510(k) clearance or commercial launch of the Peregrine™ Drivable ENT Scope70% success
  • Q4 2026Partnership or distribution agreement with a major hospital group or ENT-focused surgical center60% success
  • TBDPublication of clinical data demonstrating improved outcomes or cost savings with single-use ENT scopes50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)